1Drop Diagnostics

1Drop Diagnostics is a cutting edge medical diagnostics and life science company that combines the best techniques from microfluidics, biochemistry, photonics and information technology to build high performance point-of-care diagnostics devices.

1Drop’s goal is to improve patient lives by enabling personalized healthcare through non-invasive diagnostic tests providing actionable health information that is accessible to everyone at any time.

1Drop Diagnostics was founded in 2012 by Luc Gervais & Jörg Ziegler and is based in Neuchâtel, Neuchatel, Switzerland with an additional office in Boston, Massachusets.

1Drop facilitates the early detection, prevention and management of disease and empowers people to live better lives. It highly values collaboration, prioritizing the needs of customers and rapidly delivering solutions.

1Drop’s innovative diagnostic solutions for multiplexed assays of proteins, nucleic acids and peptides serve as tools for the development of new therapies and drugs, disease research, and clinical diagnostic tests.

 

1Drop's capillary-driven microfluidic chips automatically detect multiple biomarkers after the addition of one drop of sample, triggering a cascade of events powered by capillary forces. The chips combine microfluidic functional elements: blood filters, sample collectors, valves, channels, reaction chambers and pumps.

 

1Drop's investors include Venturelab, MassChallenge, Hans-Peter Strebel, Beat Schillig, & Jean-Philippe de Toledo. The company raised $4.3M in its most recent funding of a "Series A" round on Oct 31, 2018. This brings 1Drop's total funding to $8.1M to-date.

 

 

  • Year founded: 2012
  • Funding Info: $8.1M in 4 Funding Rounds (Last Funding Type: Series A)
  • Yearly Revenue: NA
  • Employee Size: 11-50
  • Business Valuation: NA
  • City/Town: Neuchâtel
  • State: Neuchatel
  • Country: Switzerland
Related businesses